Information for the public Natalizumab for the treatment of adults with highly active relapsing–remitting multiple sclerosis (PDF 165 KB) Published: 22 August 2007 Gwybodaeth i'r cyhoedd (Word 237 KB) Published: 07 October 2009
Natalizumab for the treatment of adults with highly active relapsing–remitting multiple sclerosis (PDF 165 KB) Published: 22 August 2007